TIMP1 and cancer: Importantly, clinical studies clearly demonstrated the association of TIMP-1 expression with therapy resistance and poor prognoses in many types of cancers [10–13 and references therein], emphasizing the potential significance of TIMP-1 as an oncogenic signaling molecule in human cancers.